Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Long-Term Deferred Tax (2017 - 2025)

Medifast's Long-Term Deferred Tax history spans 9 years, with the latest figure at $12.1 million for Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax rose 202.55% year-over-year to $12.1 million; the TTM value through Sep 2025 reached $12.1 million, up 202.55%, while the annual FY2024 figure was $11.5 million, 178.36% up from the prior year.
  • Long-Term Deferred Tax reached $12.1 million in Q3 2025 per MED's latest filing, up from $11.5 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $12.1 million in Q3 2025 to a low of $692000.0 in Q1 2021.
  • Average Long-Term Deferred Tax over 5 years is $5.8 million, with a median of $4.4 million recorded in 2021.
  • Peak YoY movement for Long-Term Deferred Tax: tumbled 66.59% in 2021, then surged 788.73% in 2022.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $4.4 million in 2021, then grew by 20.98% to $5.3 million in 2022, then fell by 22.73% to $4.1 million in 2023, then skyrocketed by 178.36% to $11.5 million in 2024, then rose by 5.65% to $12.1 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Long-Term Deferred Tax are $12.1 million (Q3 2025), $11.5 million (Q2 2025), and $11.4 million (Q1 2025).